SynCardia Systems Raises $19M

Tucson, Arizona-based Syncardia, a developer of artificial hearts, announced today that it has raised $19M in capital, including $15M in a structured financing and $4M in follow on equity. The firm said the structured financing came from Athyrium Opportunities fund. Syncardia's artificial hearts are aimed at briding heart failure patients to a transplant. The firm said its is FDA, Health Canada, and CE approved. More information »